Canada markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
10.20-0.87 (-7.86%)
At close: 04:00PM EDT
10.16 -0.04 (-0.39%)
After hours: 06:17PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 258.71M
Enterprise Value 143.63M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)295.02
Price/Book (mrq)2.20
Enterprise Value/Revenue 172.62
Enterprise Value/EBITDA -1.10

Trading Information

Stock Price History

Beta (5Y Monthly) 1.12
52-Week Change 311.14%
S&P500 52-Week Change 321.61%
52 Week High 314.75
52 Week Low 33.84
50-Day Moving Average 39.94
200-Day Moving Average 36.68

Share Statistics

Avg Vol (3 month) 3497.55k
Avg Vol (10 day) 3370.51k
Shares Outstanding 523.37M
Implied Shares Outstanding 623.37M
Float 822.99M
% Held by Insiders 11.61%
% Held by Institutions 118.06%
Shares Short (Mar 28, 2024) 42.1M
Short Ratio (Mar 28, 2024) 43.53
Short % of Float (Mar 28, 2024) 49.06%
Short % of Shares Outstanding (Mar 28, 2024) 49.00%
Shares Short (prior month Feb 29, 2024) 41.86M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Jan 25, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-26,686.29%

Management Effectiveness

Return on Assets (ttm)-32.11%
Return on Equity (ttm)-79.55%

Income Statement

Revenue (ttm)832.01k
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)-17.70%
Gross Profit (ttm)N/A
EBITDA -130.66M
Net Income Avi to Common (ttm)-135.12M
Diluted EPS (ttm)-6.09
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)145.29M
Total Cash Per Share (mrq)6.22
Total Debt (mrq)30.21M
Total Debt/Equity (mrq)25.74%
Current Ratio (mrq)3.60
Book Value Per Share (mrq)5.15

Cash Flow Statement

Operating Cash Flow (ttm)-124.37M
Levered Free Cash Flow (ttm)-86.15M